J&J Raises Forecast as Profit Climbs

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

April 17 (Bloomberg) -- Johnson & Johnson, the world’s second-biggest maker of health-care products, raised its full- year earnings forecast after quarterly profit climbed on the divestiture of an older drug and revenue from new medicines. Sheila Dharmarajan reports on Bloomberg Television's "InBusiness With Margaret Brennan." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change